To address challenges of the COVID-19 pandemic in Western Australia through research in to the Post-exposure-Prophylaxis Containing Coronavirus trial, to determine if inhaled IFNa2B therapy significantly reduces period of infection

Project Details

StatusActive
Effective start/end date1/01/2031/12/20

Funding

  • BHP Billiton Group